Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ICT2588

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Despite considerable progress with our understanding of glioblastoma multiforme (GBM) and the precise delivery of radiotherapy… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2019
2019
ICT2588 is a non-toxic MT1-MMP-activated peptide prodrug of the potent vascular disrupting agent (VDA) azademethylcolchicine [1… Expand
2014
2014
Development of therapeutic strategies for tumor-selective delivery of therapeutics through exploitation of the proteolytic tumor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
2011
2011
Vascular disrupting agents (VDA) offer a strategy to starve solid tumors of nutrients and oxygen concomitant with tumor shrinkage… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
2010
2010
Vascular disrupting agents (VDA) offer a strategy to starve solid tumors of nutrients and oxygen concomitant with tumor shrinkage… Expand
  • table 1
  • figure 5
2010
2010
Downlo cular disrupting agents (VDA) offer a strategy to starve solid tumors of nutrients and oxygen concomith tumor shrinkage… Expand
  • table 1
  • figure 5